SEAN BRYNJELSEN

CIK 1669976 · President & CEO · last filed 2026-05-29

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$27.13M

Companies

2

Total Filings

20

Lifetime Open-Market Net

-$7.15M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ETON President & CEO 858,782 $31.59 $27.13M -$7.15M 18 2026-05-29
Sagent Pharmaceuticals, Inc. (SGNT) Delisted EVP, Business Development 9,844 $0 1 2016-04-06

Recent Filings · Page 2 of 2

20 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-08-20 ETON Buy (P) +10,000 $43.2K EDGAR
2021-06-03 ETON Buy (P) +5,000 $29.8K EDGAR
2021-05-05 ETON Grant (A) $0 EDGAR
2020-03-16 ETON Grant (A) $0 EDGAR
2019-08-13 ETON Buy (P) +5,000 $30.8K EDGAR
2019-05-22 ETON Buy (P) +10,000 $79.3K EDGAR
2019-03-08 ETON Grant (A) $0 EDGAR
2018-11-15 ETON Mixed +34,940 $60.0K EDGAR
2016-08-31 Disp (D) −9,844 -$214.1K
2016-04-06 Sagent Pharmaceuticals, Inc. (SGNT) Delisted Grant (A) +9,844 $0 EDGAR
Showing 1120 of 20
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.